RESUMO
El tumor vesical presenta una elevada incidencia en nuestro medio y comporta una alta morbimortalidad asociada. Desde su sospecha clínica inicial, la confirmación diagnóstica precoz y el tratamiento multimodal involucran a diferentes especialidades médicas. Por ello consideramos importante difundir el consenso actual para su manejo. Los recientes avances en inmunología y quimioterapia hacen necesario exponer y reflexionar sobre las perspectivas futuras (AU)
Bladder cancer has a high incidence and involves high associated morbidity and mortality. Since its initial clinical suspicion, early diagnostic confirmation and multimodal treatment involve different medical specialties. For this reason, we consider it important to spread the current consensus for its management. Recent advances in immunology and Chemotherapy make it necessary to expose and reflect on future perspectives (AU)
Assuntos
Humanos , Neoplasias da Bexiga Urinária/diagnóstico , Terapia Combinada/métodos , Urotélio/imunologia , Urotélio/cirurgia , Imunoterapia/métodos , Cistectomia/métodos , Sensibilidade e Especificidade , Indicadores de Morbimortalidade , Hematúria/complicações , Cistoscopia , Estadiamento de Neoplasias , Neoplasias da Bexiga Urinária/genética , Terapia Neoadjuvante/métodosRESUMO
Bladder cancer has a high incidence and involves high associated morbidity and mortality. Since its initial clinical suspicion, early diagnostic confirmation and multimodal treatment involve different medical specialties. For this reason, we consider it important to spread the current consensus for its management. Recent advances in immunology and Chemotherapy make it necessary to expose and reflect on future perspectives.
